Author
Qianyin New Material has grown into a national high-tech enterprise integrating R&D, production, sales, and services through years of innovation and development. Its business scope covers life sciences, in vitro diagnostic raw materials, new materials, e-commerce for scientific research procurement, testing, and green energy.
As the demand for high-throughput clinical testing continues to rise, automated analyzers have become core equipment in hospital clinical laboratories and independent clinical laboratories (ICLs), placing more stringent requirements on the raw material quality of matched IVD reagents. Many industry professionals wonder: why does substrate solubility, a seemingly basic physical property, play such a pivotal role in the quality of finished IVD reagents, and even the end-to-end stability of automated testing workflows?
Within the core raw material system of IVD reagents, the reaction performance of the substrate directly defines the detection limit and upper performance ceiling of the reagent, and the impact of solubility runs through the entire testing process. Incomplete substrate dissolution produces suspended solids and undissolved particles, which not only increase reagent background interference, lead to test result drift, and cause false negative and false positive deviations, but also block the sample probes and reaction lines of automated analyzers. This drives up equipment maintenance costs and unplanned downtime risks, severely compromising the efficiency and stability of high-throughput testing.
Take Glupa-C, the core substrate for GGT (Gamma-Glutamyl Transferase) assays, as an example. High-quality Glupa-C achieves complete water solubility, zero suspended solids, and is free of foreign impurities, eliminating the above risks at the source. Its superior solubility ensures a homogeneous and stable reagent system with tighter control of intra-batch and inter-batch variation. In continuous testing runs on automated analyzers, it maintains a stable enzymatic reaction kinetic curve at all times, guaranteeing accurate and reliable test results. Meanwhile, the particle-free, clear solution drastically reduces the risk of probe clogging, perfectly adapting to the demands of round-the-clock, uninterrupted clinical testing.
With the increasing standardization and regulatory upgrading of the IVD industry, full-dimensional quality control of raw materials has become a core competitive advantage for manufacturers. Substrate solubility has also evolved from a secondary specification to a critical selection criterion for IVD reagents to adapt to automated testing scenarios.
Please check reference test at: https://www.linkedin.com/posts/hongxia-shu-0a420b38a_ivd-diagnostic-clinical-activity-7437352817331269632-nklU/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAF_IgrwB8hwrmQh3mPKGa3ae5Pxk61p5fkk
Visit us today at www.qymbiomaterial.com to explore our full range of IVD reagent substrate solutions. QYM-Your Trusted Partner for High-Purity IVD Substrates and keep your brand trustworthy with stable, cost-effective substrates.
DM us for more technical data and free samples.
whatsapp: +86-13955169746
Leave A Message
Scan to Wechat :
Scan to WhatsApp :
English
Español
IPv6 network supported